BioNTech SE BNTX
NASDAQ BNTX
$116.57 +5.68 (+5.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Sales of Property, Plant and Equipment (2018 - 2025)

BioNTech SE (BNTX) Sales of Property, Plant and Equipment (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.85 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 698,426.11
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Roivant Sciences 26.20 Bn 26.20 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 698,426.11
Dec 31, 2025 698,426.11
Sep 30, 2025 3.39 Mn
Sep 30, 2025 3.39 Mn
Jun 30, 2025 565,979.84
Jun 30, 2025 565,979.84
Mar 31, 2025 525,942.22
Mar 31, 2025 525,942.22
Dec 31, 2024 748,016.78
Dec 31, 2024 748,016.78
Sep 30, 2024 329,465.85
Sep 30, 2024 329,465.85
Jun 30, 2024 215,377.52
Jun 30, 2024 215,377.52
Dec 31, 2023 107,593.99
Dec 31, 2023 107,593.99
Sep 30, 2023 -870,872.38
Sep 30, 2023 -870,872.38
Dec 31, 2022 204,049.47
Dec 31, 2022 204,049.47